Zymeworks adds a new lab for fast-growing R&D work; Novartis considers a spinoff for Alcon
- Fast-growing Zymeworks has added a new, 10,000-square-foot lab in Vancouver to accomodate its research staff. “Zymeworks’ new lab is an investment in our …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
